Picture of Day One Biopharmaceuticals logo

DAWN — Day One Biopharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: EMA Recommends Granting Conditional Marketing Authorisation In EU For Ojemda

Feb 27 (Reuters) - EMA:

EMA: RECOMMENDED GRANTING CONDITIONAL MARKETING AUTHORISATION IN EU FOR OJEMDA (TOVORAFENIB)

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Day One Biopharmaceuticals

See all news